SCHEMBL4449241

SCHEMBL4449241

CC(=O)Nc1cccc2c(S(=O)(=O)N(C)Cc3ccccc3)cccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
HTT P42858 3/20 0.48
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HPGD P15428 1/20 0.47
KMT2A Q03164 4/20 0.47
MEN1 O00255 2/20 0.47
MAPT P10636 1/20 0.46
EDNRA P25101 1/20 0.44
GAA P10253 1/20 0.44
CNR2 P34972 2/20 0.43
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
NCOR2 Q9Y618 1/20 0.43
NAMPT P43490 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23092665 0.82 EDNRA (0.51) ALDH1A1HPGDKMT2AMEN1MAPT
SCHEMBL29900457 0.82 EDNRA (0.51) ALDH1A1HPGDKMT2AMEN1MAPT
SCHEMBL4481320 0.79 MEN1 (0.53) ALDH1A1HTTNPSR1L3MBTL1HPGD
SCHEMBL4494306 0.79 CASP6 (0.61) ALDH1A1HTTNPSR1L3MBTL1HPGD
SCHEMBL5316643 0.77 ALDH1A1 (0.64) ALDH1A1HTTHPGDKMT2AMEN1
SCHEMBL4455276 0.76 NSD2 (0.62) ALDH1A1NPSR1L3MBTL1KMT2AMEN1
Hydrochloric Acid SCHEMBL4444966 0.76 NSD2 (0.56) ALDH1A1HTTL3MBTL1HPGDKMT2A
SCHEMBL6073527 0.74 CASP6 (0.60) ALDH1A1HPGDKMT2AMEN1MAPT
SCHEMBL15461567 0.74 EDNRA (0.54) ALDH1A1HPGDKMT2AMEN1MAPT
Hydrochloric Acid SCHEMBL23092794 0.74 USP30 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7547716-B2 Sulfonamide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2009-06-16 US disclosed
EP-1402890-B1 SULFONAMIDE DERIVATIVES INST MED MOLECULAR DESIGN INC (JP) 2008-01-09 EP disclosed
US-20040234622-A1 Sulfonamide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2004-11-25 US disclosed
EP-1402890-A1 SULFONAMIDE DERIVATIVES Institute of Medicinal Molecular Design, Inc. (JP) 2004-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040234622-A1 Sulfonamide derivatives PCNA, TOP2A, DDB1 ALDH1A1 980/4885HTT 4042/4885NPSR1 2283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.